查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596152

即时PCR市场：按产品、应用和最终用户划分 - 2025-2030 年全球预测

Real-time PCR Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Forensics, Research), End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年即时PCR市场估值为 34.4 亿美元，预计 2024 年将达到 37.6 亿美元，预计复合年增长率为 9.74%，到 2030 年将达到 66 亿美元。

即时PCR也称为定量 PCR (qPCR)，是一种强大的分子生物学技术，用于目标 DNA 分子的扩增和同步定量。此方法的准确性对于基因表现分析、病原体检测、基因突变分析以及临床诊断、生物技术、法医学和实验室等领域的核酸序列测量等应用至关重要。即时PCR因其能够提供快速、准确和高效的结果而越来越受欢迎，这对于诊断感染疾病（包括 COVID-19 等流行病）越来越重要。由于基因组研究的进步、对永续农业的需求不断增加以及个人化医疗的趋势，该市场正在不断扩大，从而推动了对准确遗传评估的需求。关键的成长要素包括提高准确性和灵敏度的技术创新、政府对研发的资助增加以及对早期疾病检测的认识提高。然而，设备成本高、对熟练人员的需求以及不同平台之间标准化程度有限等挑战可能会阻碍成长。透过提高自动化程度、开发更具成本效益的设备以及扩展到实验室基础设施正在开发的开拓地区，机会将不断扩大。潜在的创新在于 qPCR 与数位技术的整合、云端基础资料分析的便利性以及现场应用可携式PCR 设备的进步。为了利用成长机会，公司应专注于多重技术和可携式设备创新的研发投资。市场竞争呈现出充满活力且未来性的轨迹，这主要是由技术进步和满足诊断需求的竞赛所推动的。调整策略以克服未发现的限制并瞄准新兴趋势可以推动永续成长和市场领导地位。

主要市场统计
基准年[2023] 34.4亿美元
预测年份 [2024] 37.6亿美元
预测年份 [2030] 66亿美元
复合年增长率（%） 9.74%

市场动态：揭示快速发展的即时PCR市场的关键市场洞察

供应和需求的动态相互作用正在改变即时PCR市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 感染疾病和遗传疾病的流行
    • 快速利用生物标记分析进行疾病诊断
    • 早期诊断致病微生物并增加临床诊断测试的使用
  • 市场限制因素
    • 即时PCR相关的设备成本较高
  • 市场机会
    • 持续技术整合和开发紧凑型、可携式、实验室晶片PC 设备
    • 从基于植物来源的药物发现快速转变为基于基因组的药物发现
  • 市场挑战
    • 即时PCR技术的技术限制和缺乏熟练的专家

波特五力：驾驭即时PCR市场的策略工具

波特五力框架是了解即时PCR市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解即时PCR市场的外部影响

外部宏观环境因素在塑造即时PCR市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解即时PCR市场的竞争状况

对即时PCR市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，使他们的公司能够应对日益激烈的竞争。

FPNV定位矩阵即时PCR市场供应商绩效评估

FPNV定位矩阵是评估即时PCR市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议描绘即时PCR市场的成功之路

即时PCR市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病和遗传疾病的传播
      • 快速利用生物标记分析进行疾病诊断
      • 病原微生物的早期诊断和临床诊断测试的增加使用
    • 抑制因素
      • 与即时PCR相关的高设备成本
    • 机会
      • 持续技术整合和开发紧凑型可携式实验室晶片单元
      • 从基于植物来源的药物发现快速转变为基于基因组的药物发现
    • 任务
      • 即时PCR技术的技术限制和缺乏熟练的专家
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章即时PCR市场：副产品

  • 装置
  • 试剂/耗材
  • 软体和服务

第七章即时PCR市场：依应用分类

  • 临床
  • 法医学
  • 调查

第 8 章即时PCR市场：依最终用户分类

  • 临床研究组织
  • 法医学研究所
  • 医院和诊断中心
  • 製药和生物技术公司
  • 研究实验室和学术机构

第九章美洲即时PCR市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区即时PCR市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲即时PCR市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Analytik Jena GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux Sweden AB
  • Bioneer Corporation
  • Danaher Corporation
  • ELITechGroup
  • Enzo Life Sciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Promega Corporation
  • QIAGEN GmbH
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-0D217D5AEDAD

The Real-time PCR Market was valued at USD 3.44 billion in 2023, expected to reach USD 3.76 billion in 2024, and is projected to grow at a CAGR of 9.74%, to USD 6.60 billion by 2030.

Real-time PCR, also known as quantitative PCR (qPCR), is a powerful molecular biology technique used for the amplification and simultaneous quantification of a targeted DNA molecule. This method is crucial for its precision in measuring nucleic acid sequences, fundamental in applications like gene expression analysis, pathogen detection, genetic variation analysis, and in areas such as clinical diagnostics, biotechnology, forensic science, and research laboratories. Real-time PCR is gaining traction due to its ability to deliver rapid, accurate, and efficient results, which is increasingly critical for diagnosing infectious diseases, including prevalent issues such as COVID-19. The market is expanding due to advancements in genomic research, a growing demand for sustainable agriculture practices, and personalized medicine trends, fueling the need for precise genetic assessments. Key growth factors include technological innovations improving accuracy and sensitivity, increased governmental funding for R&D, and rising awareness of early disease detection. However, challenges such as the high cost of equipment, the need for skilled personnel, and limitations in standardization across different platforms might hinder growth. Opportunities thrive in enhancing automation, developing more cost-effective devices, and expanding into untapped regions where laboratory infrastructure is developing. Potential innovations lie in integrating qPCR with digital technologies, promoting cloud-based data analytics, and advancing portable PCR devices for field applications. To capitalize on growth opportunities, firms should focus on R&D investments in multiplexing techniques and portable device innovations. The market is competitive, driven heavily by technological advancements and the race to meet diagnostic demands, indicating a dynamic and future-forward trajectory. Adjusting strategies to overcome identified limitations and targeting emerging trends can facilitate sustained growth and market leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 3.44 billion
Estimated Year [2024] USD 3.76 billion
Forecast Year [2030] USD 6.60 billion
CAGR (%) 9.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Real-time PCR Market

The Real-time PCR Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of infectious diseases and genetic disorders
    • Rapid utilization of biomarker profiling for disease diagnostics
    • Rising early diagnosis of disease-causing microbes and the use of clinical diagnostic tests
  • Market Restraints
    • High device costs associated with real-time PCR
  • Market Opportunities
    • Ongoing technological integration and development of compact, portable, and lab-on-chip PCR devices
    • Rapid shift from plant-derived to genome-based drug discovery
  • Market Challenges
    • Technical limitations of real-time PCR techniques and lack of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Real-time PCR Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Real-time PCR Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Real-time PCR Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Real-time PCR Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Real-time PCR Market

A detailed market share analysis in the Real-time PCR Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Real-time PCR Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Real-time PCR Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Real-time PCR Market

A strategic analysis of the Real-time PCR Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Real-time PCR Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Analytik Jena GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux Sweden AB, Bioneer Corporation, Danaher Corporation, ELITechGroup, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, QIAGEN GmbH, Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Real-time PCR Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Application, market is studied across Clinical, Forensics, and Research.
  • Based on End Users, market is studied across Clinical Research Organizations, Forensic Laboratories, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, and Research Laboratories & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of infectious diseases and genetic disorders
      • 5.1.1.2. Rapid utilization of biomarker profiling for disease diagnostics
      • 5.1.1.3. Rising early diagnosis of disease-causing microbes and the use of clinical diagnostic tests
    • 5.1.2. Restraints
      • 5.1.2.1. High device costs associated with real-time PCR
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological integration and development of compact, portable, and lab-on-chip PCR devices
      • 5.1.3.2. Rapid shift from plant-derived to genome-based drug discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of real-time PCR techniques and lack of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Real-time PCR Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Software & Services

7. Real-time PCR Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical
  • 7.3. Forensics
  • 7.4. Research

8. Real-time PCR Market, by End Users

  • 8.1. Introduction
  • 8.2. Clinical Research Organizations
  • 8.3. Forensic Laboratories
  • 8.4. Hospitals & Diagnostic Centers
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Research Laboratories & Academic Institutes

9. Americas Real-time PCR Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Real-time PCR Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Real-time PCR Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Analytik Jena GmbH
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux Sweden AB
  • 6. Bioneer Corporation
  • 7. Danaher Corporation
  • 8. ELITechGroup
  • 9. Enzo Life Sciences, Inc.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Merck KGaA
  • 12. Promega Corporation
  • 13. QIAGEN GmbH
  • 14. Takara Bio Inc.
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. REAL-TIME PCR MARKET RESEARCH PROCESS
  • FIGURE 2. REAL-TIME PCR MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. REAL-TIME PCR MARKET DYNAMICS
  • TABLE 7. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL REAL-TIME PCR MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL REAL-TIME PCR MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL REAL-TIME PCR MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL REAL-TIME PCR MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL REAL-TIME PCR MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL REAL-TIME PCR MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL REAL-TIME PCR MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 148. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2023